Back to User profile » Dr Maximilian Gabler
Papers published by Dr Maximilian Gabler:
Healthcare Resource Utilization and Associated Costs in New Users of Empagliflozin versus DPP-4 Inhibitors and GLP-1 Agonists: A Comparative Analysis Based on Retrospective Real-World Data from German Sickness Funds
Wilke T, Picker N, Müller S, Stürmlinger A, Deiters B, Dittmar A, Aberle J, Gabler M
ClinicoEconomics and Outcomes Research 2022, 14:319-332
Published Date: 2 May 2022
Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage [Corrigendum]
Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M
Diabetes, Metabolic Syndrome and Obesity 2019, 12:1397-1398
Published Date: 14 August 2019
Real-world insulin therapy in German type 2 diabetes mellitus patients: patient characteristics, treatment patterns, and insulin dosage
Wilke T, Picker N, Mueller S, Geier S, Foersch J, Aberle J, Martin S, Riedl M, Gabler M
Diabetes, Metabolic Syndrome and Obesity 2019, 12:1225-1237
Published Date: 24 July 2019